respiratori
diseas
common
sourc
morbid
mortal
among
children
health
care
provid
often
face
dilemma
encount
febril
infant
child
respiratori
tract
infect
reason
express
mani
clinician
troubl
confirm
whether
fever
caus
viru
bacterium
aim
review
updat
current
evid
virusinduc
bacteri
infect
present
sever
clinic
well
vitro
studi
support
correl
viru
secondari
bacteri
infect
addit
discuss
pathophysiolog
prevent
mode
virusbacterium
coexist
search
pubm
medlin
databas
carri
publish
articl
cover
bacteri
infect
associ
respiratori
virus
review
provid
clinician
comprehens
idea
rang
bacteri
viral
coinfect
secondari
infect
could
present
viral
respiratori
ill
viral
respiratori
tract
infect
vrti
common
children
present
vari
simpl
cold
lifethreaten
infect
detect
respiratori
viru
necessarili
infer
child
viral
infect
sinc
outbreak
vrti
link
increas
incid
bacteri
coinfect
human
bodi
usual
capabl
elimin
respiratori
viral
infect
sequela
howev
case
virus
bypass
immun
respons
airway
caus
conceiv
sever
respiratori
diseas
robust
mechan
immunosuppress
process
protect
lung
extern
infect
singl
respiratori
tract
infect
might
chang
immun
patholog
health
care
provid
often
face
dilemma
encount
febril
infant
child
respiratori
tract
infect
reason
express
mani
clinician
challeng
confirm
whether
fever
caus
viru
bacterium
acut
otiti
media
aom
usual
bacteri
coinfect
occur
case
vrti
addit
almost
children
vrti
chang
maxillari
ethmoid
frontal
sinus
moreov
year
estim
million
individu
die
influenza
pandem
mani
due
secondari
bacteri
pneumonia
streptococcu
pneumonia
search
pubm
databas
googl
carri
use
differ
combin
follow
term
viru
induc
bacteria
pathogenesi
prevent
vaccin
children
addit
search
refer
identifi
articl
addit
articl
review
abstract
titl
includ
studi
submit
manuscript
wwwdovepresscom
hendau
et
al
relev
topic
interest
final
search
limit
studi
diseas
human
publish
english
spanish
end
figur
epithelium
figur
usual
cover
layer
mucu
function
boundari
mucin
charg
glycoprotein
main
compon
mucu
common
mucin
human
sputum
assist
innat
immun
system
antiinflammatori
antivir
properti
addit
facilit
trap
clearanc
virus
howev
overproduct
mucin
might
paradox
effect
airway
epithelium
function
physic
barrier
also
recogn
microorgan
pattern
recognit
receptor
tolllik
receptor
tlr
nucleotidebind
oligomer
domain
nod
like
receptor
nlr
retino
acidinduc
gene
rig
like
helicas
tlr
singl
noncatalyt
membranespan
receptor
protein
use
innat
immun
system
respiratori
virus
collabor
tlr
lane
lead
extend
bacteri
load
lung
comparison
nlr
riglik
helicas
activ
innat
immun
respons
cytosol
sens
viral
bacteri
compon
famili
member
nlr
induc
molecul
synthes
product
andor
degrad
bacteri
peptidoglycan
addit
mani
epitheli
cell
express
classic
antivir
interferon
inf
especi
moreov
respiratori
virusinfect
epithelia
facilit
attract
inflammatori
cell
includ
natur
killer
cell
neutrophil
macrophag
eosinophil
bloodstream
infect
site
final
airway
epithelium
consist
mani
molecul
includ
intercellular
adhes
molecul
carcinoembryon
antigenrel
cellular
adhes
plateletactiv
factor
receptor
pafr
virus
effect
modul
receptor
lead
increas
risk
bacteri
adher
exampl
rhinoviru
upregul
express
pafr
lead
bind
pneumonia
bronchial
epitheli
cell
differ
mechan
might
contribut
debilit
host
defens
respiratori
tract
bacteria
follow
viral
infect
mechan
extrapol
studi
conduct
anim
model
sequenti
infect
respiratori
virus
sever
bacteri
pathogen
mammalian
cell
prone
bacteri
attach
viral
ill
virus
debilit
mucociliari
clearanc
structur
lead
increas
attach
bacteria
mucin
colon
moreov
condens
mucu
imped
penetr
antibacteri
materi
immun
cell
virus
like
respiratori
syncyti
viru
rsv
damag
ciliat
cell
result
ciliostasi
therefor
deterior
mucociliari
clearanc
concept
appli
influenza
viru
infect
lead
decreas
tracheal
mucociliari
veloc
clearanc
pneumonia
moreov
virusinduc
cell
death
debilit
mechan
elimin
attach
pathogen
display
novic
receptor
bacteri
adher
studi
shown
rsv
viru
induc
adher
pneumonia
pseudomona
aeruginosa
haemophilu
influenza
airway
epitheli
cell
addit
adenoviru
rhinoviru
play
role
adher
pneumonia
airway
epitheli
cell
howev
measl
viru
decreas
risk
adher
streptococc
bacteria
impli
everi
viru
specif
mode
chang
host
cell
membran
moreov
bacteri
adhes
might
also
result
upregul
surfac
receptor
includ
pafr
involv
pneumococc
invas
patient
cystic
fibrosi
bacteri
adher
form
biofilm
creat
perman
airway
colon
p
aeruginosa
virus
rsv
rhinoviru
influenza
viru
also
lead
pneumococc
biofilm
format
airway
line
furthermor
rsv
increas
risk
adher
staphylococcu
aureu
bordetella
pertussi
human
epidermoid
cancer
epitheli
cell
viru
effect
immun
system
postvir
sustain
desensit
lung
sentinel
cell
tlr
signal
may
one
possibl
contributor
common
secondari
bacteri
pneumonia
associ
viral
infect
instanc
pathway
alter
influenza
viru
infect
result
decreas
neutrophil
attract
therebi
lead
increas
attach
pneumonia
p
aeruginosa
airway
epitheli
cell
interrel
host
cell
microorgan
infect
induc
immun
respons
includ
gener
proinflammatori
molecul
despit
crucial
role
bactericid
proinflammatori
cytokin
produc
respons
infect
could
detriment
host
cell
viral
infect
tlr
rigilik
receptor
activ
induc
product
type
ifn
augment
inflammatori
respons
tlr
ligand
includ
lipopolysaccharid
lp
addit
certain
bacteria
aureu
integr
respiratori
epitheli
cell
adenocarcinom
hendau
et
al
humanalveolar
basalepitheli
cell
respiratori
viral
infect
increas
express
rsv
differ
influenza
viru
former
upregul
cellular
receptor
includ
eventu
lead
bacteri
infect
final
interact
type
ifn
signal
lead
bacteri
recognit
indict
harm
effect
viral
infect
host
anoth
studi
show
rate
bacteremia
om
respect
children
viralinduc
bronchiol
highest
incid
aom
usual
day
upper
respiratori
infect
isol
virus
alon
sinu
aspir
concomit
bacteria
propos
role
virus
induct
bacteri
sinus
rhinoviru
parainfluenza
virus
culprit
rate
bacteremia
children
acut
bronchiol
rang
addit
rate
bacteri
urinari
tract
infect
uti
children
bronchiol
high
recent
studi
hendau
et
al
human
myxoviru
resist
protein
mxa
import
intermediari
ifninduc
antivir
respons
varieti
virus
mxa
express
firmli
modifi
type
type
iii
ifn
also
requir
signal
transduc
activ
transcript
signal
addit
mxa
mani
characterist
similar
superfamili
larg
guanosin
triphosphatas
mxa
analysi
could
benefici
differenti
bacteri
viral
infect
engelmann
et
al
conduct
prospect
multicent
cohort
studi
differ
pediatr
emerg
depart
franc
role
mxa
diagnosi
viral
infect
mxa
blood
valu
calcul
infant
children
verifi
bacteri
viral
infect
uninfect
control
infect
unknown
origin
receiv
oper
characterist
analysi
use
verifi
diagnost
perform
mxa
studi
includ
children
show
mxa
significantli
higher
children
viral
versu
bacteri
infect
uninfect
control
addit
mxa
level
significantli
higher
children
clinic
diagnos
viral
infect
clinic
diagnos
bacteri
infect
author
also
report
use
blood
mxa
test
patient
viral
infect
use
mxa
diagnos
viral
infect
promis
especi
patient
risk
infecti
complic
two
separ
studi
shown
blood
mxa
benefici
differenti
viral
ill
acut
graftversushost
diseas
allogen
stem
cell
transplant
recommend
treatment
prevent
viral
diseas
may
superior
method
diminish
also
publish
live
attenu
influenza
vaccin
effect
reduc
incid
allcaus
aom
pneumonia
compar
placebo
children
addit
intranas
influenza
vaccin
reduc
om
moreov
studi
shown
combin
influenzapneumococc
vaccin
effici
prevent
om
children
pneumonia
howev
credit
protect
award
influenza
vaccin
sinc
studi
shown
pneumococc
vaccin
benefit
reduct
aom
addit
pneumococc
polysaccharid
vaccin
show
efficaci
prevent
pneumonia
adult
treatment
viral
infect
anticip
prevent
bacteri
superinfect
current
respiratori
viru
pharmacolog
treatabl
influenza
virus
type
b
neuraminidas
inhibitor
potenti
diminish
morbid
relat
influenza
oseltamivir
reduc
incid
aom
preschool
children
reduct
rate
metaanalysi
review
show
oral
oseltamivir
reduc
rate
hospit
morbid
addit
use
reduc
use
antibiot
concept
protect
appli
vaccin
prevent
rsv
infect
vaccin
avail
rsv
palivizumab
medimmun
gaithersburg
md
usa
human
monoclon
antibodi
perceiv
fusion
protein
rsv
monoclon
antibodi
clinic
trial
motavizumab
medimmun
higher
affin
rsv
fusion
protein
palivizumab
prevent
medic
attend
lower
respiratori
tract
infect
rate
concurr
seriou
bacteri
infect
viral
ill
appreci
similar
emphasi
must
given
prevent
treatment
viral
ill
especi
young
children
furthermor
health
care
provid
emphas
parent
import
clinic
followup
infant
young
children
diagnos
vrti
moreov
introduct
mxa
diagnosi
viral
ill
children
promis
author
declar
conflict
interest
work
